DGAP-Ad-hoc: Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results/Change in Forecast
Drägerwerk AG & Co. KGaA: preliminary result for the third quarter. Guidance reduced.

15-Oct-2018 / 15:02 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Ad-hoc notification in accordance with Sec. 17 of the MAR

Drägerwerk AG & Co. KGaA: preliminary result for the third quarter. Guidance reduced.

Dräger has announced preliminary, unaudited figures for the third quarter of 2018.

In the third quarter, Dräger recorded year-on-year growth in order intake of 7.6 percent (net of currency effects; nominal: 5.0 percent). The Americas and the Asia, Australia, and Africa regions in particular saw strong growth in order intake. Net sales development, however, lagged behind the positive order intake trend. Certain currencies relevant to Dräger continued to lose a substantial amount of value compared to the euro over the course of the third quarter, which had a negative impact on net sales volume in euros and, consequently, on earnings as well. At roughly EUR 613 million (Q3 2017: EUR 621.0 million), net sales were down 1.2 percent year on year. Net of currency effects, the Group's net sales were up 1.3 percent. EBIT for the quarter stood at around EUR -4.4 million, down significantly on the prior year (Q3 2017: EUR 24.4 million). The lower earnings were caused by a decline in net sales volume, a weaker gross margin, and higher costs, particularly as a result of the ongoing investment program into R&D and specific sales capabilities.

Order intake therefore increased by 3.8 percent year on year in the first nine months of 2018 (net of currency effects; nominal: 0.2 percent). All three regions recorded higher order intake year on year (net of currency effects). At around EUR 1.729 million, the Group's net sales were down 0.4 percent on the prior year (9 months 2017: EUR 1,737.0 million). Net of currency effects, net sales were up 3.0 percent. Total EBIT stood at approximately EUR -41 million (9 months 2017: EUR 43.5 million). In particular, the devaluation of certain emerging markets' currencies over the course of the year, which was very significant in some cases, contributed to the negative earnings. As planned, Dräger is investing more in its R&D activities and in sales with the aim of strengthening its future prospects. However, unplanned expenses in logistics and for quality-related measures also had a negative impact on earnings for the first nine months of the year.

For the year as a whole, Dräger continues to expect net sales growth of between 2.0 and 5.0 percent (net of currency effects). Due to the additional negative effects resulting from the strong euro, however, Dräger will probably no longer be able to achieve its original EBIT forecast for the year. The EBIT margin will probably only amount to between 2.0 and 3.5 percent for 2018. Based on the latest developments, Dräger currently does not expect exchange rates to recover. The company also plans to continue its investment into sales and innovation. As a result, profitability will not improve substantially next year either. The detailed forecast for 2019 will be published along with the final business figures for the current fiscal year.

Dräger will publish its full results for the first nine months of the fiscal year on October 30, 2018.

Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23558 Lübeck, Deutschland
www.draeger.com

Investor Relations:
Thomas Fischler
Tel. +49 451 882-2685
thomas.fischler@draeger.com

Corporate Communications:
Melanie Kamann
Tel. +49 451 882-3998
melanie.kamann@draeger.com


Disclaimer
This ad hoc report contains statements on the future development of Dräger Group. These forward-looking statements are based on the current expectations, presumptions, and forecasts of the Executive Board as well as the information available to date. They were compiled to the best of the company's knowledge. Dräger does not provide any warranty nor assume any responsibility for the future developments and results described above. These are dependent on a number of factors. They entail various risks and contingencies outside of the company's influence and are based on assumptions which could prove to be incorrect. Dräger does not assume any responsibility for updating the forward-looking statements contained in this report. This does not infringe any legal stipulations on the adjustment of forecasts. Please go to Investor Relations / Definitions of financial indicators at www.draeger.com for information on alternative performance measures used.


15-Oct-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23542 Lübeck
Germany
Phone: +49 (0)451 882-0
Fax: +49 (0)451 882-2080
E-mail: info@draeger.com
Internet: www.draeger.com
ISIN: DE0005550602, DE 000 555 063 6, DE 000 555 065 1, DE 000 555 067 7, DE 000 555 071 9
WKN: 555060, 555063 Vorzüge, 555065 Genussschein A, 555067 Genussschein K, 555071 Genussschein D
Indices: SDAX, TecDAX
Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich; Regulated Unofficial Market in Stuttgart, Tradegate Exchange

 
End of Announcement DGAP News Service

733627  15-Oct-2018 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=733627&application_name=news&site_id=zonebourse